Bresotec’s BresoDX1 secures FDA clearance for at-home sleep apnea testing
BresoDX1 is indicated for use in the diagnosis of moderate to severe sleep apnea in adults in an…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Jan 23
BresoDX1 is indicated for use in the diagnosis of moderate to severe sleep apnea in adults in an…
22 Dec 22
The tests were performed to assess potential health risks with the polyester-based PE-PUR sound abatement foam in specific…
22 Dec 22
The AI.ME robotic system utilizes an advanced visualization system, machine vision, and Artificial Intelligence algorithms to target the…
20 Dec 22
The FDA clearance is backed by the results of a trial involving 68 women at four sites in…
19 Dec 22
Presently under development, the CT-132 digital therapeutic candidate has secured the FDA designation in patients of age 18…
13 Dec 22
Agilent Resolution ctDx FIRST is said to offer NSCLC patients and their oncologists a new minimally invasive blood…
08 Dec 22
This product provides a massager-like fingertip swab, a collection tube and a lid with unidirectional sampling inlet
08 Dec 22
The MIRIA system is the only FDA cleared laser product that more than doubles the current therapeutic energy…
30 Nov 22
The wearable and portable Optune device delivers TTFields therapy to the region of the tumour
24 Nov 22
The recall is based on reports of interference to other nearby critical medical devices by radiofrequency emissions from…